Project Details
Description
A two-cohort, open-label, single arm, multicenter study to evaluate efficacy, safety and tolerability, pharmacokinetics and pharmacodynamics, of emapalumab in children and adults with
Status | Active |
---|---|
Effective start/end date | 7/26/21 → 8/31/26 |
Funding
- SOBI, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.